Taking advantage of the possibility of tracking these dedifferentiated β-cells in lineage-tracing experiments in mouse models of diabetes, Wang and colleagues demonstrated that insulin therapy stimulates in vivo the redifferentiation of the dedifferentiated β-cells into mature NGN3−/INS+ β-cells [90]. The gene discussed is INS; the disease is diabetes mellitus.